Development of Multiplex RT-PCR with Immobilized Primers for Identification of Infectious Human Pneumonia Pathogens

S A Lapa1, R A Miftakhov1, E S Klochikhina1

  • 1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.

Molecular Biology
|December 27, 2021
PubMed

Insights

A new multiplex reverse transcription PCR (RT-PCR) system detects multiple pneumonia pathogens, including bacteria, influenza A, and SARS-CoV-2. This sensitive, contamination-resistant platform enhances infectious disease diagnostics.

Area of Science:

  • Molecular Biology
  • Infectious Disease Diagnostics
  • Biotechnology

Background:

  • Pneumonia is a significant global health concern caused by diverse bacterial and viral pathogens.
  • Accurate and rapid detection of these pathogens is crucial for effective treatment and public health management.
  • Existing diagnostic methods may lack multiplexing capabilities or suffer from sensitivity issues.

Purpose of the Study:

  • To develop and prototype a novel multiplex system for the simultaneous detection of common pneumonia pathogens.
  • To enhance diagnostic sensitivity and reduce background noise in pathogen detection.
  • To create a contamination-resistant platform suitable for high-throughput sample analysis.

Main Methods:

  • Development of a multiplex solid-phase reverse transcription PCR (RT-PCR) assay.
  • Design of specific primers for six bacterial and two viral (Influenza A, SARS-CoV-2) pneumonia pathogens.
  • Utilized fluorescently labeled nucleotides for signal accumulation and detection through a reaction chamber's cover film.

Main Results:

  • The prototype system successfully detected multiple pneumonia pathogens in a single test.
  • Signal detection through the cover film minimized background noise, increasing analytical sensitivity.
  • The system demonstrated suitability for simultaneous testing of numerous samples with reduced cross-contamination risk.

Conclusions:

  • The developed multiplex RT-PCR system offers a sensitive and efficient method for detecting infectious pneumonia pathogens.
  • The platform's design facilitates high-throughput testing and minimizes contamination, improving diagnostic workflows.
  • The open architecture allows for future expansion to detect a broader range of pathogenic microorganisms.